The Coca-Cola Co K vs Revvity Inc — how do they compare? The Coca-Cola Co K trades at $82.06 (market cap $353.32B), while Revvity Inc trades at $110.88 (market cap $11.87B). The key difference: The Coca-Cola Co K is far larger — about 29.8× Revvity Inc's market cap, and The Coca-Cola Co K pays the higher dividend (2.58%). Which is the better fit depends on your goals.
| KO | RVTY | |
|---|---|---|
Market Cap | $353.32B | $11.87B |
Volume | 14,630,257 | — |
Sector | Consumer Staples | Technology |
52-Week High | $84.92 | $117.75 |
52-Week Low | $65.67 | $82.26 |
Enterprise Value | $383.39B | $14.36B |
Dividend Yield | 2.58% | 0.26% |
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $82.05, up 0.6% with a bearish technical signal but strong fundamentals including 27.8% net margin and consistent earnings beats. Recent quarterly EPS exceeded expectations, while analyst consensus is bullish with a $90.67 price target. The company maintains robust cash flow and a 64-year dividend growth streak, supported by stable demand trends noted by Bank of America on April 10, 2026.
Outlook remains positive due to valuation upside and dividend reliability, though technical resistance near $83 and high debt levels pose risks. Investors benefit from defensive positioning amid market volatility, but must monitor regional demand fluctuations and interest rate impacts on borrowing costs.
RVTY trades at $106.44, down 3.37% today, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 4, 2026. Recent developments include AI integration partnerships and FDA clearances, supporting growth in its diagnostics and life sciences segments. Valuation metrics show a P/E of 52.96 and P/S of 4.35, reflecting premium pricing for its growth prospects.
The stock presents a balanced opportunity with analyst consensus pointing to 4.7% upside to the $111.43 price target. Strong institutional ownership and zero sell ratings indicate confidence, though high valuation multiples and negative cash flow trends pose risks. Earnings momentum from recent beats and strategic AI expansions provide catalysts, but investors should monitor margin pressures and China market exposure highlighted in recent quarters.
Trailing returns across standard periods
Latest headlines on both assets
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →